Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Myria Biosciences
Myria Biosciences is revolutionizing drug discovery by integrating synthetic biology, artificial intelligence, and super-speed analytics to create AI-designed microbes that produce novel therapeutic…
Myria Biosciences
Myria Biosciences is revolutionizing drug discovery by integrating synthetic biology, artificial intelligence, and super-speed analytics to create AI-designed microbes that produce novel therapeutic…
TL;DR
Headquarters: Basel, Switzerland
Tech: AI-guided biosynthesis (GEMMS), synthetic biology
Stage: Pre-seed (closed Q1 2024)
Founding team: Steven Schmitt (CEO), Kenan Bozhüÿck (CSO), Irene Wüthrich (COO)
Employees: ~10
Company Overview
Problem Domain
Drug discovery and development focused on natural product–inspired molecules produced via synthetic biology.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
Pre-seed round closed in Q1 2024; investors reported include Creator Fund and Rockmount Seed Investments; company described raising a bridge to reach seed readiness.
Investor Signal
“Creator Fund led the pre-seed; additional investors reported include Rockmount Seed Investments and Capital Blue Partners”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week